Therapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis

BACKGROUND AND AIM: Mucosal healing in inflammatory bowel disease (IBD) can be achieved by improvement of intestinal barrier protection. Activation of hypoxia-inducible factor (HIF) has been identified as a critical factor for barrier protection during mucosal insult and is linked with improvement i...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Gupta, Ram, Chaudhary, Anita R, Shah, Binita N, Jadhav, Avinash V, Zambad, Shitalkumar P, Gupta, Ramesh Chandra, Deshpande, Shailesh, Chauthaiwale, Vijay, Dutt, Chaitanya
פורמט: Artigo
שפה:Inglês
יצא לאור: Dove Medical Press 2014
נושאים:
Original Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3908906/
https://ncbi.nlm.nih.gov/pubmed/24493931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S51923
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים